Skip to main content

Table 7 Comparison of polypnea scores before and after treatment

From: Therapeutic effect of subcutaneous injection of low dose recombinant human granulocyte-macrophage colony-stimulating factor on pulmonary alveolar proteinosis

(A): Changes of polypnea scores before treatment and after 6 months of treatment (n = 20)
Scores before treatmentScores after 6 months of treatmentNumber of cases
114
214
314
323
414
511
(B): Changes of polypnea scores before treatment and after 12 months of treatment (n = 17)
Scores before treatmentScores after 12 months of treatmentNumber of cases
101
112
201
211
231
302
313
321
331
413
511
  1. The score of polypnea was also improved before and after 6 months of treatment, with significant difference (z = 3.562, P = 0.000011). Seventeen patients were followed up after 12 months, and compared with that before treatment, the polypnea after 12 months of treatment was also improved, with statistically significant difference (z = 3.830, P = 0.000128)